Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection

Line K. Vibholm, Ole S. Søgaard, Katrine Laura Rasmussen et al.|Clinical Infectious Diseases|2017

Cited by 146